1. Home
  2. BNZI vs TSBX Comparison

BNZI vs TSBX Comparison

Compare BNZI & TSBX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BNZI
  • TSBX
  • Stock Information
  • Founded
  • BNZI 2016
  • TSBX 2015
  • Country
  • BNZI United States
  • TSBX United States
  • Employees
  • BNZI N/A
  • TSBX N/A
  • Industry
  • BNZI
  • TSBX
  • Sector
  • BNZI
  • TSBX
  • Exchange
  • BNZI Nasdaq
  • TSBX Nasdaq
  • Market Cap
  • BNZI 9.5M
  • TSBX 8.4M
  • IPO Year
  • BNZI N/A
  • TSBX 2023
  • Fundamental
  • Price
  • BNZI $1.03
  • TSBX $0.30
  • Analyst Decision
  • BNZI Strong Buy
  • TSBX Buy
  • Analyst Count
  • BNZI 1
  • TSBX 3
  • Target Price
  • BNZI $125.00
  • TSBX $4.75
  • AVG Volume (30 Days)
  • BNZI 1.2M
  • TSBX 86.9K
  • Earning Date
  • BNZI 04-15-2025
  • TSBX 05-12-2025
  • Dividend Yield
  • BNZI N/A
  • TSBX N/A
  • EPS Growth
  • BNZI N/A
  • TSBX N/A
  • EPS
  • BNZI N/A
  • TSBX N/A
  • Revenue
  • BNZI $4,527,879.00
  • TSBX N/A
  • Revenue This Year
  • BNZI $430.54
  • TSBX N/A
  • Revenue Next Year
  • BNZI N/A
  • TSBX N/A
  • P/E Ratio
  • BNZI N/A
  • TSBX N/A
  • Revenue Growth
  • BNZI N/A
  • TSBX N/A
  • 52 Week Low
  • BNZI $0.74
  • TSBX $0.32
  • 52 Week High
  • BNZI $20.50
  • TSBX $3.39
  • Technical
  • Relative Strength Index (RSI)
  • BNZI 45.21
  • TSBX 31.62
  • Support Level
  • BNZI $0.98
  • TSBX $0.29
  • Resistance Level
  • BNZI $1.25
  • TSBX $0.41
  • Average True Range (ATR)
  • BNZI 0.11
  • TSBX 0.03
  • MACD
  • BNZI 0.01
  • TSBX -0.01
  • Stochastic Oscillator
  • BNZI 32.71
  • TSBX 21.29

About BNZI Banzai International Inc.

Banzai International Inc is a marketing technology (MarTech) company that produces data-driven marketing and sales solutions for businesses of all sizes. Its mission is to help its customers accomplish their mission by enabling better marketing, sales and customer engagement outcomes. The company sells its products using a recurring subscription license model typical in SaaS businesses. Pricing tiers for its main product, Demio, are based on the number of host-capable users, desired feature sets, and maximum audience size.

About TSBX Turnstone Biologics Corp.

Turnstone Biologics Corp is a clinical-stage biotechnology company focused on developing new medicines to treat and cure patients with solid tumors. The company is pioneering a differentiated approach to tumor-infiltrating lymphocytes, or TILs, a clinically validated technology for treating solid tumors. It is developing next-generation TIL therapies by selecting the most potent and tumor-reactive T cells, which are referred to as Selected TILs. TILs are a type of cell therapy that harnesses the patient's own immune cells to target their own tumors. TIL therapy involves the isolation of lymphocytes from the patient's tumor, expansion of the isolated cells outside the body, and then infusion of the cells back into the patient.

Share on Social Networks: